openPR Logo
Press release

Long-Term Investors in Orthofix Medical Inc. who lost money with NASDAQ: OFIX shares should contact the Shareholders Foundation

10-25-2023 01:29 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of investors in Orthofix Medical Inc. (NASDAQ: OFIX) shares over potential wrongdoing.

An investigation on behalf of investors in Orthofix Medical Inc. (NASDAQ: OFIX) shares over potential wrongdoing.

An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Orthofix Medical Inc.

Investors who purchased shares of Orthofix Medical Inc. (NASDAQ: OFIX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Orthofix Medical Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.

Lewisville, TX based Orthofix Medical Inc. operates spine and orthopedics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. Orthofix Medical Inc. reported that its annual Total Revenue declined from $464.47 million in 2021 to $460.71 million in 2022, and that its Net Loss declined from $25.54 million in 2021 to $19.74 million in 2022.

On September 12, 2023, Orthofix Medical Inc. announced the termination of its CEO, CFO, and CLO. The Company stated, "The Board's decision follows an investigation conducted by independent outside legal counsel and directed and overseen by the Company's independent directors. As a result of the investigation, the Board determined that each of these executives engaged in repeated inappropriate and offensive conduct that violated multiple code of conduct requirements and was inconsistent with the Company's values and culture. These matters are unrelated to and do not impact the Company's strategy, results of operations or previously filed financial statements."

Shares of Orthofix Medical Inc. (NASDAQ: OFIX) declined from $21.60 per share on August 31, 2023, to as low as $10.54 per share on October 11, 2023.

Those who purchased shares of Orthofix Medical Inc. (NASDAQ: OFIX) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Long-Term Investors in Orthofix Medical Inc. who lost money with NASDAQ: OFIX shares should contact the Shareholders Foundation here

News-ID: 3261569 • Views:

More Releases from Shareholders Foundation

Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, 2025
Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, …
A deadline is coming up on September 12, 2025in the lawsuit filed for certain investors of Biohaven Ltd. (NYSE: BHVN) over alleged securities laws violations by Biohaven Ltd. Investors who purchased shares of Biohaven Ltd. (NYSE: BHVN) have certain options and there are strict and short deadlines running. Deadline: September 12, 2025. NYSE: BHVN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the
Investigation announced for Long-Term Investors in shares of West Pharmaceutical Services, Inc. (NYSE: WST) over potential Wrongdoing
Investigation announced for Long-Term Investors in shares of West Pharmaceutical …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of West Pharmaceutical Services, Inc.. Investors who are current long term investors in West Pharmaceutical Services, Inc. (NYSE: WST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in (NYSE: WST stocks follows a lawsuit filed
Investigation announced for Long-Term Investors in Open Lending Corporation (NASDAQ: LPRO) over potential Wrongdoing
Investigation announced for Long-Term Investors in Open Lending Corporation (NAS …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Open Lending Corporation. Investors who are current long term investors in Open Lending Corporation (NASDAQ: LPRO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: LPRO stocks follows a lawsuit filed against Open
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings, Inc. (NYSE: BBAI)
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings …
An investigation on behalf of current long-term investors in shares of BigBear.ai Holdings, Inc. (NYSE: BBAI) concerning potential breaches of fiduciary duties by certain directors and officers of BigBear.ai Holdings, Inc. was announced. Investors who are current long term investors in BigBear.ai Holdings, Inc. (NYSE: BBAI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm

All 5 Releases


More Releases for Orthofix

Orthobiologics Market Growth Statistics & Future Prospects | Medtronic, Orthofix …
The latest study released on the Global Orthobiologics Market by HTF MI Research evaluates market size, trend, and forecast to 2031. The Orthobiologics market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors. Key Players in This
Extremity Reconstruction Market Hits New High | Major Giants Orthofix,TriMed,Bio …
HTF MI just released the Global Extremity Reconstruction Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach. Major companies profiled in Extremity Reconstruction Market are: Stryker, Zimmer Biomet,
Osgood-Schlatter Market is Experiencing Significant Growth | Bioventus, Acumed, …
The Latest published market study on Global Osgood-Schlatter Market provides an overview of the current market dynamics in the Osgood-Schlatter, as well as what our survey respondents all outsourcing decision-makers predict the market will look like in 2032. The study breaks the market by revenue and volume (wherever applicable) and price history to estimate the size and trend analysis and identify gaps and opportunities. Some of the players that are
Spinal Implants Market Dynamics 2028 | Orthofix International N.V.
Global Spinal Implants Market: Overview Rapidly growing population and significantly increase in the treatment rate of degenerative spine disorders are the key factors driving demand in the global spinal implants market. Changing the lifestyle that led to the growth of obesity among the masses has further augmented growth for spinal implants. Increasing spine injuries due to increasing sports activities and other reasons are also benefitting growth in this market. Moreover, the
Radiolucent Wrist Fixator Market 2018 - 2028 | Orthofix, Stryker, Smith & Nephew
Market Outlook External fixation devices have been used since a long time. However, these external fixation devices have a number of drawbacks such as risk of infection, stiffness of the joint, discomfort due to weight and hindrance in X-Ray for monitoring the heeling progress. The radiolucent wrist fixators help in reducing the bulk as they are lighter making them a convenient option for patients. External fixation devices can be used for
Medical Bionic Implant Market to 2019 – 2024: Opportunity & Growth Analysis by …
A fresh report has been added to the wide database of Business Industry Reports. The research study is titled “Medical Bionic Implant Market” by Manufacturers, Countries, Type and Application, Forecast to 2024 which provides important data about the production, consumption, revenue and company profiles for key industry participants. Global Medical Bionic Implant Market Synopsis: This report studies the Global Medical Bionic Implant Market over the forecast period of 2019 to 2024. The